Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
30.20
-2.34 (-7.19%)
Nov 20, 2026, 4:00 PM EST - Market closed
Nektar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $153 → $149 | Buy | Reiterates | $153 → $149 | +393.38% | Nov 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $185 | Buy | Maintains | $185 | +512.58% | Nov 16, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $130 | Buy | Reiterates | $130 | +330.46% | Nov 13, 2026 |
| Wedbush | Wedbush | Hold Maintains $50 → $40 | Hold | Maintains | $50 → $40 | +32.45% | Nov 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $192 | Buy | Maintains | $192 | +535.76% | Nov 13, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $140 | Buy | Maintains | $140 | +363.58% | Nov 13, 2026 |
| UBS | UBS | Hold Initiates $53 | Hold | Initiates | $53 | +75.50% | Oct 12, 2026 |
| BTIG | BTIG | Buy Maintains $178 | Buy | Maintains | $178 | +489.40% | Oct 9, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.